Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
351 !
|
Tue, 7/31/2018,
10:30 AM -
12:20 PM
|
CC-West 219
|
|
Statistical Issues Specific the Therapeutic Areas- 3 — Contributed Papers
|
|
Biopharmaceutical Section
|
|
Chair(s): Dong Xi, Novartis Pharmaceuticals
|
|
10:35 AM
|
A Graphical Dissection of the Log-Rank Test and Cox Proportional Hazards Model
Xiaofei Hu, Abbvie; Yabing Mai, AbbVie, Inc
|
|
10:50 AM
|
Unexpected Safety Signals in Dose Escalation Process
Chunzhang Wu, Astellas Pharma Global Development, Inc.
|
|
11:20 AM
|
The Impact of Misspecification of Linear Modeling on the Prediction in SMART PK/PD Clinical Trials
Tian Zhao, Merck; Li Fan, Merck
|
|
11:35 AM
|
Modeling Overall Survival Under Immuno-Oncology Therapies with Long-Term Survival Models
Junshui Ma, Merck & Co., Inc.; Keaven Anderson, Merck & Co., Inc.
|
|
11:50 AM
|
Recurrent Events Analysis Using Landmark Andersen-Gill Model with Time-Varying Covariates
Zheyu Liu, Bayer Pharmaceuticals; Vivian Lanius, Bayer AG; Dejian Lai, The University of Texas Health Science Center at Houston
|
|
